Content area
Full Text
CHICAGO - After 71 years operating primarily as a contract manufacturer, Xttrium Labs is making a strong play into the generic and private label industries this year with as many as 12 abbreviated new drug application filings scheduled for submission in 2006, mostly for drugs in liquid formulations.